It was designed by Al-Obeidi, Castrucci, Hadley and Hruby and reported in the Journal of Medicinal Chemistry in 1989, using quenched molecular dynamics to select which conformation of the alpha-MSH 4-10 message sequence to constrain
doi: 10.1111/dom.14280 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Automated Insulin Delivery ADA Only The ADA made sweeping changes to AID recommendations in 2026: AID is now the preferred insulin delivery method for all people with type 1 diabetes AID is preferred for adults and children with T2D on multiple daily injections, CSII, or sensor-augmented pump therapy AID should be offered to all adults with T1D or T2D on insulin AID can be considered in T2D on basal insulin who are not meeting glycemic goals No C-peptide level, islet autoantibody status, or insulin duration is required before starting CSII or AID Children and adolescents must be supported in device use at school
You can view our comprehensive chart available to learn more about specific dosage and cycling guidelines
The surge reflects its incredible effectiveness
Contributing: Katie Camero